Start an analysis for TECH
Bio-Techne Corp.
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $505m | 30-Sep-26 | 10-Q filed 06-Nov-26 |
| Remaining authorization | $363m | 30-Sep-26 | 10-Q filed 06-Nov-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | $0 | 30-Sep-26 | 10-Q filed 12-Nov-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 30-Apr-25 | $505m | $363mEST | n/a | the Board approved a new share repurchase plan on April 30, 2025, to replace the previous share repurchase plan, that authorizes the Company to purchase up to $505 million of the Company’s outstanding common stock.10-Q filed 06-Nov-26 |
Open-market repurchases
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 30-Sep-26 | 0 | — | $0 | 10-Q filed 12-Nov-26 |
| 31-Aug-26 | 0 | — | $0 | 10-Q filed 12-Nov-26 |
| 31-Jul-26 | 0 | — | $0 | 10-Q filed 12-Nov-26 |